# Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma

> **NCT00036140** · PHASE1 · COMPLETED · sponsor: **Pfizer**

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Investigational drug

## Key facts

- **NCT ID:** NCT00036140
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00036140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00036140, "Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00036140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*